We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
To own Align today, you have to believe in the long term appeal of clear aligners and integrated digital dentistry, despite softer case starts and equipment budgets. In the near term, a key catalyst is execution on modest 2026 growth and margin targets, while the biggest risk remains pressure on aligner volumes and pricing. Elliott’s activist stake may influence capital deployment and cost discipline, but it does not fundamentally change those underlying demand and margin questions yet.
The SprintRay Midas World Tour collaboration is particularly relevant here, because it reinforces iTero’s role at the center of same day restorative workflows. At a time when dentists have been cautious about big-ticket scanner purchases, seeing iTero embedded in a broader, practice-friendly ecosystem matters for the thesis that scanners and digital workflows can still support Align’s growth and margin ambitions, even if aligner demand and pricing remain under pressure.
But while these partnerships are encouraging, investors should also be aware of the risk that sustained discounting and lower aligner pricing could...
Read the full narrative on Align Technology (it's free!)
Align Technology's narrative projects $4.5 billion revenue and $674.8 million earnings by 2028.
Uncover how Align Technology's forecasts yield a $198.67 fair value, a 13% upside to its current price.
The most bearish analysts were assuming only about 1.6 percent annual revenue growth to US$4.2 billion by 2028 and a lower PE multiple, so compared with the current catalyst focus on digital workflows and activist pressure, they paint a much more cautious picture that could shift again as this new Elliott involvement and scanner partnerships play out.
Explore 6 other fair value estimates on Align Technology - why the stock might be worth as much as 28% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com